MedTrace Logo

Distal Protection Device in ST-elevation Myocardial Infarction (STEMI)

NCT01384019 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2013-03-18

Study results available
· View outcomes & findings →

Summary

The investigators examined the mechanism underlying the lack of benefit from distal protection and thrombus aspiration (DP-TA) in 126 patients with ST-elevation Myocardial Infarction (STEMI) in a prospective, randomized trial.

Conditions

  • ST-segment Elevation Myocardial Infarction

Interventions

DEVICE

distal protection and thrombus aspiration (The GuardWire Plus (Medtronic Inc.))

The GuardWire Plus (Medtronic Inc.): distal balloon occlusion and proximal thrombus aspiration

PROCEDURE

c-PCI

conventional PCI without Guard wire

Sponsors & Collaborators

  • Seoul National University Bundang Hospital

    lead OTHER

Principal Investigators

  • Dong-ju Choi, MD · Seoul National University Bundang Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Primary Completion
2008-06-30
Completion
2011-08-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01384019 on ClinicalTrials.gov